Su Jin Choi

Dr. Su Jin Choi


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2021 in Rheumatology International
Verified
Journal Article
Open access
PDF file
YJYoung Hun Jeon
Young Hun Jeon
DLDoo-Ho Lim
Doo-Ho Lim
SCSeung Won Choi
Seung Won Choi
SCSu Jin Choi
Su Jin Choi
Vaccination is a cornerstone for reducing the risk of COVID-19 infection during a pandemic. Although the currently used COVID-19 vaccine is considered safe, some concerns persist regarding the likelihood of flares of rheumatic diseases. Still’s disease is a rare auto-inflammatory disorder of unknown etiology, and the data on the flare of Still’s disease following COVID-19 vaccination are limited. Therefore, we hereby present the case of a 34-year-old female patient with Still’s disease who experienced a flare after a ChAdOx1 nCoV-19 vaccination. The patient visited the emergency department complaining of fever, arthralgia, myalgia, pleuritic chest pain and macular salmon-pink rash on her back for the past 2 days. She had maintained low Still’s disease activity with etanercept and low-dose glucocorticoid for 14 years. She received the ChAdOx1 nCoV-19 vaccine 7 days before the flare. Laboratory investigations revealed leucocytosis and elevated serum levels of erythrocyte sedimentation rate, C-reactive protein, and ferritin. Computed tomography showed no specific findings. She received methylprednisolone pulse therapy, etanercept, and methotrexate for treating the Still’s disease flare. However, her symptoms were not fully controlled, and she developed pericarditis, pleuritis, fever and macular rashes expanding to her extremities. After excluding infectious conditions by blood culture and pleural fluid analysis, we administered tocilizumab with methotrexate and prednisolone. Her symptoms and laboratory findings improved significantly, and she was discharged without symptoms 7 days later. Although rare, this case of a patient with Still’s disease undergoing a flare following vaccination suggests that close observation of disease activity is warranted following COVID-19 vaccination.

1 June 2025 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
KPKi-Bong Park
Ki-Bong Park
MHMinsu Han
Minsu Han
SCSu Jin Choi
Su Jin Choi
GPGyung-Min Park
Gyung-Min Park
YJYoung-Jee Jeon
Young-Jee Jeon
DLDoo-Ho Lim
Doo-Ho Lim
Background: Uric acid (UA) may influence bone health through its antioxidant and pro-oxidant properties. While previous studies have investigated the relationship between serum UA levels and bone mineral density (BMD), their findings have been conflicting. This study aimed to examine the impact of serum UA levels on BMD in peri- and postmenopausal Korean women. Methods: We evaluated 3,566 women aged 50–80 years who voluntarily underwent laboratory tests and BMD measurements as part of a general health examination between March 2014 and March 2020. Participants were stratified into quartiles according to their serum UA levels. Univariate and multivariate analyses were performed to assess the association between serum UA levels and BMD. Results: The mean age of the participants was 56.9±5.8 years. BMD at the lumbar spine and hip was significantly higher in women with elevated serum UA levels, showing a continuous increase across the quartiles. Furthermore, after adjusting for covariates, the mean total lumbar spine BMD increased from 0.892 g/cm² (95% CI: 0.884–0.900) in the lowest UA quartile to 0.918 g/cm² (95% CI: 0.909–0.927) in the highest quartile (P<0.001). Similarly, the adjusted total hip BMD was higher in the highest UA quartile at 0.847 g/cm² (95% CI: 0.840–0.854) compared with 0.828 g/cm² (95% CI: 0.821–0.834) in the lowest quartile (P=0.001). Conclusion: Our results suggest that elevated serum UA levels are associated with higher BMD in peri- and postmenopausal Korean women, indicating a potential protective role in bone metabolism.

23 September 2025 in Arthritis Care & Research
Verified
Journal Article
Open access
JNJihyun Na
Jihyun Na
SCSu Jin Choi
Su Jin Choi
SPSojeong Park
Sojeong Park
MPMinae Park
Minae Park
DLDoo-Ho Lim
Doo-Ho Lim
Objective: Systemic sclerosis (SSc) is a rare autoimmune disease characterized by tissue fibrosis, vasculopathy, and immune dysregulation. Our objectives were to quantify the overall and site‐specific cancer risks in patients with SSc compared to the general population, examine temporal trends in cancer incidence following SSc diagnosis, and explore potential associations with immunosuppressive agent use. Methods: Using data from the Korean National Health Insurance Service, we identified 6,386 patients newly diagnosed with SSc between 2004 and 2020. Standardized incidence ratios (SIRs) were calculated to compare the risk of cancer between patients with SSc and the general population. Subgroup analyses were performed based on age at diagnosis, follow‐up duration, and immunosuppressive agent use. Results: Most patients (80.2%) were women, with a mean ± SD age at diagnosis of 53.1 ± 13.4 years. Patients with SSc had higher risks of overall cancer (SIR 3.12; 95% confidence interval [CI] 2.92–3.33), solid cancer (SIR 3.07; 95% CI 2.86–3.28), and hematologic cancer (SIR 5.70; 95% CI 4.50–7.11) compared to the general population. Myelodysplastic syndrome (SIR 12.52; 95% CI 7.00–20.65) had the highest risk, followed by multiple myeloma, eye, Hodgkin lymphoma, and larynx cancers. Cancer risk peaked among patients aged 20 to 39 years (SIR 5.27; 95% CI 4.31–6.38) and during the first year after diagnosis (SIR 4.44; 95% CI 3.81–5.14). Conclusion: In this study, we revealed that the incidence of cancer is higher in patients with SSc in South Korea compared to the general population. The strong association between SSc and cancer occurrence prompts clinicians to conduct careful cancer screening for patients with SSc.

1 January 2025 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
SCSu Jin Choi
Su Jin Choi
MSMin Wook So
Min Wook So
SLSunggun Lee
Sunggun Lee
SCSeung Won Choi
Seung Won Choi
DLDoo-Ho Lim
Doo-Ho Lim
In contrast to experimental studies indicating the neuroprotective role of uric acid (UA), recent clinical studies have shown that increased UA is associated with a risk of acute hemorrhagic stroke. However, the association of UA with intraventricular hemorrhage (IVH) has not been adequately evaluated. In this study, we determined the relationship between UA and IVH in patients with intracerebral hemorrhage (ICH). We included 721 patients with ICH who were admitted to a tertiary hospital in South Korea. The patients were stratified into quartiles based on their UA levels. IVH decreased continuously across all quartiles of UA. After adjusting for confounding factors, the odds ratio (OR) for IVH was significantly lower in the fourth quartile compared with that in the first quartile (OR: 0.713; 95% CI: 0.546–0.934; P=0.045). In conclusion, UA is independently associated with IVH, suggesting its protective role against IVH in patients with ICH.

17 June 2025 in Journal of Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
YOYoonkyo Oh
Yoonkyo Oh
SCSu Jin Choi
Su Jin Choi
DLDoo-Ho Lim
Doo-Ho Lim
Yoonkyo Oh, M.D., Su Jin Choi, M.D., Doo-Ho Lim, M.D., Ph.D.. J Rheum Dis -0001;0:. https://doi.org/10.4078/jrd.2025.0060

19 October 2026 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
SCSu Jin Choi
Su Jin Choi
SPSojeong Park
Sojeong Park
MPMinae Park
Minae Park
SCSeung Won Choi
Seung Won Choi
DLDoo-Ho Lim
Doo-Ho Lim